Your body already knows. Now we can translate it.
Cancer changes biology long before it appears on a scan, biopsy, or lab report.
Hessian Labs reads those changes directly through platelet proteomics - capturing the real-time biological signals that drive disease progression, therapeutic response, and clinical outcomes.
This creates a new biological information layer for precision oncology.
Not just whether cancer is present…But how it’s behaving.
001 Our Science
Biology First
smarter clinical decision support
Healthcare runs on events—imaging, biopsies, pathology, and treatment decisions.
But cancer biology evolves long before those events occur.
Most diagnostics measure structure, mutation, or disease presence. Few reveal what the disease is actively doing.
Hessian Labs measures functional tumor biology directly through platelet proteomics—providing clinicians with clearer, earlier, and more actionable insights.
Because better decisions start with better biology.
002 Processfunctional.
dynamic.
actionable.
HeLP™ personalized diagnostics provide disease-specific insights by reading the proteins carried in platelets—offering a dynamic, real-time view of cancer biology from a simple blood draw.
Built on our proprietary ClariaIQ™ molecular informatics platform, HeLP™ tests are designed to support earlier detection, risk stratification, treatment monitoring, and disease surveillance.
Current programs include:
HeLP™ PC — Prostate Cancer
HeLP™ BC — Breast Cancer
HeLP™ MC — Multi-Cancer Detection
Precision diagnostics should not wait for disease to become obvious.
They should reveal biology early enough to change outcomes.
003 Why it mattersEXISTING DIAGNOSTICS DESCRIBE DISEASE.
WE HELP EXPLAIN ITS BEHAVIOR.
Imaging shows where disease is.
Pathology shows what tissue looks like.
Genomics reveals mutations that may influence risk.
But none fully explain whether disease is aggressive, dormant, responding to treatment, or beginning to return.
Platelet proteomics captures the active biological programs driving those outcomes—angiogenesis, immune evasion, invasion, proliferation, and resistance.
This helps clinicians move from reacting to events…
to anticipating biology.
004 clinical impactEARLIER DETECTION. BETTER DECISIONS.
FEWER UNNECESSARY PROCEDURES.
Hessian Labs is advancing diagnostics that help reduce unnecessary biopsies, improve treatment selection, detect relapse earlier, and support more personalized care.
From prostate cancer to breast cancer - and beyond - our goal is simple:
Give patients and physicians clearer answers when decisions matter most.